Global Breast Cancer Diagnostics Market Analysis, Growth Drivers, Trends and Future Forecast till 2022

FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research “Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to market volume, regional expanse as well as competitive landscape prevailing in the global breast cancer diagnostics market. In order to study development patterns, this smart assessment also focuses on market dynamics, which talks about drivers, restraints and opportunities estimated to influence the concerned market during the period until 2017 to 2022.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Key Estimations for the Global Breast Cancer Diagnostics Market

1- By test type, BRCA will remain dominant in the global breast cancer diagnostics market.

2- CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.

3- HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.

4- North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.

5- Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.

6- Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.

7- Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.

8- Key market players mentioned in Fact.MR’s report include Siemens AG, Myriad Genetics, Inc., Roche Holding AG, Illumina, Inc., Epigenomics AG, Abbott Laboratories, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., Biocept, Inc., AstraZeneca plc, and Quest Diagnostics Incorporated.

Browse Full Report With TOC- https://www.factmr.com/report/55/breast-cancer-diagnostics-market

Table of Content

Chapter 5 Global Breast Cancer Diagnostics Market Analysis and Forecast By Region 68
5.1 Global Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 68
5.1.1 North America Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 68
5.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 68
5.1.1.2 Revenue (US$ Mn) Comparison, By End User 70
5.1.2 Latin America Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 72
5.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 72
5.1.2.2 Revenue (US$ Mn) Comparison, By End User 74
5.1.3 Europe Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 76
5.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 76
5.1.3.2 Revenue (US$ Mn) Comparison, By End User 78
5.1.4 Japan Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 80
5.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 80
5.1.4.2 Revenue (US$ Mn) Comparison, By End User 82
5.1.5 APEJ Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 84
5.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 84
5.1.5.2 Revenue (US$ Mn) Comparison, By End User 86
5.1.6 MEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 88
5.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 88
5.1.6.2 Revenue (US$ Mn) Comparison, By End User 90

Chapter 6 North America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 92
6.1 US Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 92
6.1.1 Revenue (US$ Mn) Comparison, By Test Type 92
6.1.2 Revenue (US$ Mn) Comparison, By End User 93
6.2 Canada Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 94
6.2.1 Revenue (US$ Mn) Comparison, By Test Type 94
6.2.2 Revenue (US$ Mn) Comparison, By End User 95

Chapter 7 Latin America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 96

Continued@@@...

Check For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=55

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.